Prognostic Value of Postoperative Blood Levels of Carcinoembryonic Antigen (CEA) in Breast Cancer

  • R. E. Myers
  • D. J. A. Sutherland
  • J. W. Meakin
  • D. G. Malkin
  • J. A. Kellen
  • A. Malkin
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 67)

Abstract

Carcinoembryonic antigen (CEA) was originally described by GOLD in 1965. Initial studies suggested that this assay might provide a method for identifying patients with colon cancer. However, the early promise of specificity for colon cancer has not been confirmed by the antigen and antibody preparations currently available and, in fact, abnormally elevated levels of CEA have been found in a wide variety of tumours, other non-malignant diseases, and after blood transfusion. More refined antigen and antibody preparations hold promise of greater specificity [3].

With the relatively recent discovery that adjuvant chemotherapy and hormone therapy can reduce recurrence rates in premenopausal breast cancer patients, it becomes important to have means of selecting patients at high risk of recurrence. Traditionally, histological nodal status has served this function. Other tests of prognosis are required when the axillary nodes are negative. Furthermore, in patients with metastatic disease in particular, when one is comparing different treatment regimens, it is important to have means of assuring that different groups of patients are comparable.

Keywords

Assure Hines 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gehan, E. A.: A generalized Wilcoxon test for comparing arbitrarily singly-sensored samples. Biometrika 52, 203–223 (1965)PubMedGoogle Scholar
  2. 2.
    Hansen, H. J., Snyder, J. J., Miller, E., Vandevoorde, J. P., Miller, O. N., Hines, L. R., Burns, J. J.: Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum. Pathol. 5, 139–147 (1974)PubMedCrossRefGoogle Scholar
  3. 3.
    Maugh II, T. H.: CEA: Puzzling new information about a useful marker. Science 197, 544 (1977)Google Scholar
  4. 4.
    Myers, R. E., Sutherland, D. J. A., Kellen, J. A., Malkin, D. G., Malkin, A.: CEA in breast cancer. Cancer (in press) (1978)Google Scholar
  5. 5.
    Wang, D. Y., Bulbrook, R. D., Hayward, J. L., Hendrick, J. C., Franchimont, P.: Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer. Eur. J. Cancer 11, 615–618 (1975)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1979

Authors and Affiliations

  • R. E. Myers
  • D. J. A. Sutherland
  • J. W. Meakin
  • D. G. Malkin
  • J. A. Kellen
  • A. Malkin

There are no affiliations available

Personalised recommendations